UNICHEM LAB has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Jun-18* | 3 Mar-19* | 3 Jun-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 2,014 | 2,771 | 2,325 | -16.1% | 15.4% |
Other income | Rs m | 193 | 226 | 280 | 24.1% | 44.9% |
Turnover | Rs m | 2,207 | 2,996 | 2,605 | -13.1% | 18.0% |
Expenses | Rs m | 2,401 | 2,819 | 2,506 | -11.1% | 4.4% |
Gross profit | Rs m | -387 | -48 | -181 | ||
Depreciation | Rs m | 123 | 177 | 169 | -4.9% | 36.5% |
Interest | Rs m | 0 | 4 | 0 | -88.6% | 291.7% |
Profit before tax | Rs m | -317 | -4 | -70 | ||
Tax | Rs m | -110 | -41 | -75 | ||
Profit after tax | Rs m | -207 | 37 | 5 | -87.4% | |
Gross profit margin | % | -19.2 | -1.7 | -7.8 | ||
Effective tax rate | % | 34.8 | 1,066.8 | 106.6 | ||
Net profit margin | % | -9.4 | 1.2 | 0.2 |
To see how UNICHEM LAB has performed over the last eight quarters,please visit here.
Over the last one year,UNICHEM LAB share price has moved down from Rs 224.6 to Rs 163.9, registering a Loss of Rs 60.7 or around 27.0%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,965.0 (up 1.3%). Over the last one year it has moved down from 14,122.7 to 12,965.0, a gain of 1,158 points (down 8.2%).
Overall, the S&P BSE SENSEX is up 1.1% over the year.
At the current price of Rs 163.9, the price to earnings (P/E) ratio of UNICHEM LAB stands at 52.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 0.6 times.
Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.
For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More
| |
Equitymaster requests your view! Post a comment on "UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!